0
Description
The Omnitrope Pen is an easy-to-use injection tool for HGH therapy. The pen makes it easy for both doctors and their patients dealing with growth hormone deficiency. It allows for both consistency and precision in dosing and administration. The therapy imitates the body’s natural hormonal production of HGH with regular injections.
Omnitrope is made by Sandoz; which is a division of Swiss company named Novartis, a pharmaceutical leader in generic pharmaceuticals. The HGH comes in premixed cartridges that need to be kept refrigerated. Their delivery device is called the SurePal which as the name implies is easy to use. Simply slide the cartridge into the device, screw the needle tip on, dial in the dosage and inject. Omnitrope offers the best value and has a worldwide market share of around 8%.
The pen consists of multiple parts. The medication comes in small cartridges, which must be refrigerated. HGH in the cartridge lasts for approximately 28 days once opened.
Omnitrope is administered under the skin just before bedtime. When you’re ready for your Omnitrope injection, remove one cartridge from the refrigerator, 30 minutes before use. Load the cartridge into the pen use the dial on the non-needle side of the pen to choose the correct dose for injection. Once the needle is primed, and air bubbles removed, it’s ready for injection.
In the United States, the Omnitrope Pen price runs from $700 upwards of $1,000 for one month supply of Omnitrope Pens.
